Decipher Labs Quarterly Results for Trading Insights
Latest Quarter Net Profit
₹0 Cr
QMar 2026
In Mar 2026, Decipher Labs (DECIPHER) reported revenue ₹4 Cr and net profit ₹0 Cr. Analyse DECIPHER shareholding pattern to track promoter, FII and institutional holdings.
DECIPHER Quarterly Results — Revenue, Profit & EPS Highlights
Decipher Labs latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View DECIPHER 52-week chart for the annual high/low range and current price position.
- Revenue of ₹4 Cr in Mar 2026 (+33.3% vs Jun 2026, +0.0% vs Mar 2025)
- Operating Margin of 6.0% in Mar 2026 (+96.0pp vs Jun 2026)
- Earnings Per Share of ₹-0.35 in Mar 2026 (+83.8% vs Jun 2026)
Decipher Labs Quarterly Results — Revenue, EBITDA, Net Profit & EPS
DECIPHER quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Jun 2026 | Sept 2025 | Mar 2025 | Jun 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 4 | 3 | 4 | 4 | 3 | 33.3% | - |
| Net Profit (₹ Cr) | 0 | -2 | 0 | -4 | -3 | - | - |
| EBITDA (₹ Cr) | 0 | -2 | 0 | -6 | -3 | - | - |
| EPS (₹) | -0.35 | -2.16 | 0.02 | -4.07 | -3.39 | - | - |
| Operating Margin (%) | 6.0% | -90.0% | 3.0% | -188.0% | -114.0% | - | - |
DECIPHER Share Price Trend — 1-Year Movement Across Quarterly Results
Decipher Labs 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit DECIPHER share price.
Revenue Trend (₹ Cr)
Mar 2025
4
Sept 2025
4
Jun 2026
3
Mar 2026
4
Net Profit Trend (₹ Cr)
Mar 2025
-4
Sept 2025
0
Jun 2026
-2
Mar 2026
0
Operating Margin Trend (%)
Mar 2025
-188.0%
Sept 2025
3.0%
Jun 2026
-90.0%
Mar 2026
6.0%
DECIPHER vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Decipher Labs latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹441,477.63 Cr | 1837.3 | 15,018 | 2,710 | -5.6% | - | 18.0% | 162.6 |
|
Divis Laboratories
Mar 2026 |
₹247,469.81 Cr | 9375.0 | 2,986 | 751 | -5.0% | - | 25.2% | 331.2 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹188,719.51 Cr | 4840.0 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 420.5 |
|
Cipla
Mar 2026 |
₹112,654.03 Cr | 1394.5 | 6,612 | 543 | -9.3% | - | 8.2% | 203.0 |
|
Zydus Life Science
Mar 2026 |
₹112,607.65 Cr | 1160.0 | 7,569 | 1,341 | -4.3% | - | 17.7% | 91.7 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores